| Tag | Content |
|---|
EnhancerAtlas ID | HS012-16285 |
Organism | Homo sapiens |
Tissue/cell | Caco-2 |
Coordinate | chr2:85932370-85933290 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NKX2-3 | MA0672.1 | chr2:85932925-85932935 | ACCACTTGAA | + | 6.02 |
|
| | Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
| SE_09507 | chr2:85927524-85942538 | CD14 | | SE_20317 | chr2:85928061-85934777 | CD56 | | SE_32403 | chr2:85932284-85934546 | Gastric | | SE_42161 | chr2:85932033-85934925 | Lung | | SE_48223 | chr2:85932005-85935003 | Psoas_Muscle | | SE_51392 | chr2:85931708-85934902 | Skeletal_Muscle |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I085701 | chr2 | 85928201 | 85934922 |
|
Enhancer Sequence | CTGTTGTTTT CAACAATGCC TTTTATGGAA AAACAAACCA TGTTTTTCCT CTGCTCTTAC 60
ACCAACACAA CAACAATCAA CACAGAAGAC TTCTCTGACT CCTAAATACG TGGCTGTTTC 120
TCCCCACCAG CAAGCAAGCA GTCAGTTCCG CAGTGGACAC CAGCTAGGTG TCCTCCAACT 180
CAATTCTGAC GCTATTTATC TGGAGACAGT GTCAGATCCC ACAGGTTGGG GGCTCAGTCC 240
CCATAATTGC CTTGGCAGAT TTGGGATTTG AATCCAGGCA GTCTTAGCTG TGAACCACCA 300
CACAAATCCA CCTTTCTCCA AAGAATGGAG GCCTGAGCTC CCTTGTAACT TGGGGTAAAT 360
AATCTGGGCA CATATCCTTG AGGAATAGCA GGACCAGAAT GCTCTGCACA GGACTGGAAA 420
TGGCTGGGGG GAGGAAAACC AAGTCCCTGA CAGTGTTGAC CATTTCCTTC ATCCTGTGAG 480
GCAATGGGCT TGACCCTGCA ATGTTCCCAG CACAAGTCTG AGGAGTGATG CAATAGAGAG 540
TGGGTGAGTT GAGTAACCAC TTGAAATTCC ACTCCTCTCT TCCCTTTTCA TAACAGGTGT 600
CCTAACTTTC TGCCAAGCAC ACTCAGGTTT TCCATGTTCT GCTTAGAAGT TACCAACTGG 660
CTGTTGGTTA GGCCTAGCAA ATTATGTAGA CTTCTTTTCG GCTAAGAATC ATAGCAAGTT 720
TATTCCCTCA GGGTAGGAAG GTCATATTTT TTCTTTAGGC TCCACCTTGG TCTTCCCTCG 780
GAAGGGGAAA TAGGAATTCT TTCTTCCTCA GGATGAGCTC GTATAAGGCC AGGCTCATTG 840
ATGATAAGAA GCAGAAATGG ACTCAGCCTA AATTAAGACA AGGGAAGTGA CAGGGCGGCC 900
ATGGCTGCCA CAGGATGGAA 920
|
